Demis Hassabis claims AI can cure all diseases within 10 years, backed by a $2.1B funding round for Isomorphic Labs to accelerate AI-driven drug discovery and personalized medicine.
Demis Hassabis says he can cure every disease in 10 years. Most people roll their eyes when they hear this, but I don't. Demis is the guy who just won the Nobel Prize for solving protein folding with AI (a problem biologists had been stuck on for 50 years). But that was just one milestone in his much grander plan. In 2010, he founded DeepMind with a 2-part mission: "solve intelligence, then use it to solve everything else." Step 1: make AI good enough to do real science. Step 2: point that AI at humanity's biggest problems. Step one was AlphaFold. He used AI to figure out the 3D shape of every protein in nature (which is basically what every drug attaches to). Demis said it would have taken "a billion years of PhD time" to do by hand. Step two is curing all disease. And as of today, step two is fully funded. Isomorphic Labs (his AI drug discovery company inside Google) just raised $2.1B led by Thrive Capital. Here's where the money goes and what Demis thinks happens next: > Drug discovery currently takes 5-10 years and costs billions per drug. That math is why most diseases don't have good treatments today. > AI fixes the math. Their drug design engine compresses development from years to months. Maybe weeks. > Isomorphic's first AI-designed cancer drug enters human trials this year. > Their pipeline expands beyond the current 17 programs across cancer, immune diseases, and heart disease into more health domains. > The endgame is personalized medicine: drugs designed overnight for your specific biology and your specific disease. That last one is the whole point. Today's drugs are mass-produced for an "average" patient who doesn't really exist. So most existing treatments work inconsistently from person to person, and most rare diseases never get a treatment at all (no market = no drug). When drug design gets fast and cheap, that whole calculus flips. Cancer variants get drugs designed for that specific variant, rare diseases get treatments because economics stop mattering, and drug-resistant infections get new drugs faster than they can evolve. That's what curing every disease actually looks like. Now imagine what your life looks like in 2036. A doctor draws your blood, sequences your genome, sends your disease profile to an AI. By morning the AI has designed a custom drug for your specific biology. Side effects, dosage, drug interactions all worked out before you take the first pill. You and your kids never see a cancer ward. That's what $2.1B is buying today. Demis was right about AlphaFold. If you consider the possibility that he's right again, every disease alive today is on borrowed time.
Demis Hassabis, co-founder of Google DeepMind, announces $2.1 billion in funding for Isomorphic Labs to use AI to cure all diseases by accelerating drug discovery.
Dario Amodei, CEO of Anthropic, argues that AI could cure most human diseases within 5-10 years and stresses the need for real results to address public trust issues in AI.
A critical analysis of Google DeepMind CEO Demis Hassabis's claim at Google I/O that AI could 'solve all diseases,' contextualizing the potential of tools like AlphaFold and AlphaGenome while highlighting the gap between scientific promise and public perception.
Isomorphic Labs, an AI-driven drug discovery company founded by Demis Hassabis, announced a $2.1 billion Series B funding round led by Thrive Capital to scale its business and advance its AI drug design engine, IsoDDE.
The article critiques unrealistic claims that AI will cure all human diseases in 5-10 years, emphasizing that we cannot even measure most diseases and that such projections damage credibility.